Our study is aimed at investigating the effect of C. lacerata on improving glycemic markers, insulin resistance, and insulin sensitivity of T2DM patients through a 12-week randomized, double-blind, placebo-controlled clinical trial. The gene discussed is INS; the disease is Insulin resistance.